-
Finance & Investment
A group with a marked entrepreneurial spirit, Tolefi regularly invests in new areas of activity and companies that share the values and long-term vision. Through this targeted, diversified approach, the group has stakes in various companies. These are aligned with the CSR policy, in sectors for the future, and offering strong growth potential.
-
Celyad
-
CBo Territoria
-
-
Celyad
Celyad Oncology SA (formerly Cardio 3 SA) is a clinical-stage biotechnology company focused on the discovery and development of CAR T (Chimeric Antigen Receptor) cell therapies for the treatment of cancer. These treatments consist of stimulation of the patient's immune system.
Accompanied by the Tolefi group since its creation in 2007, the company is developing a pipeline of allogeneic (ready-to-use) and autologous (customised) CAR T cell therapy product candidates for the treatment of solid and hematological tumors. Celyad Oncology SA is supported by the Walloon Region (Belgium) for the advancement of its CAR T cell therapy programs. Celyad is now listed on the Brussels, Paris and Nasdaq stock exchanges.
BMS SA, (also called clean rooms) intended for the storage of therapeutic products. -
CBo Territoria
CBO Territoria is a global real estate operator active in the departments of La Réunion and Mayotte. A landowner operating upstream and throughout the value chain, CBO Territoria develops a diversified real estate offer (housing and building land, commercial and business premises) for professionals and individuals. CBO Territoria quickly became the benchmark local player in real estate in La Réunion.